A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition that causes breathing difficulties by blocking ...

For patients with chronic obstructive pulmonary disease (COPD), the Global Initiative on Obstructive Lung Disease recommends long-term term pharmacologic and nonpharmacologic therapies based on each ...

Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain risk factors for COPD, including obesity and ...

On World COPD Day, experts highlight that while COPD is treatable, it can't be reversed; awareness and prevention are crucial ...

Chronic respiratory failure is associated with earlier and greater risks of cardiovascular diseases among individuals with COPD.

Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly ...

Today is World COPD Day, and the American Lung Association is spotlighting a free program to provide personalized, one-on-one support to people living with COPD. The Lung Health Navigator program is ...

Merck on Tuesday said its drug, Winrevair, met the primary endpoint in a Phase 2 study in adults with post- and precapillary pulmonary hypertension due to heart failure. The Rahway, N.J., ...